RTI Health Solutions' parent company, RTI International, has been recognized by Forbes Magazine for its diverse workplace. The annual 2020 list of the ‘Best Employers for Diversity’—released each year by Forbes—ranked RTI #277 out of 500 companies based on a survey of nearly 60,000 employees at...
Recurring ear infections in children are not only frustrating and painful–they can also cause serious complications. If antibiotics do not successfully treat an ear infection or if infections continue to occur, a physician may recommend the insertion of ear tubes. Until now that has required the...
Answers to key questions about the communication of information for unapproved products as well as unapproved uses of approved products.
Pharmacoepidemiology, now in its sixth edition, provides comprehensive guidance available for anyone needing up-to-date information in pharmacoepidemiology.
We have conducted a review of publicly available information on scientific advice services offered by HTA bodies
Health technology assessments are becoming more influential in countries where payers were traditionally not using value-based pricing methods for pricing negotiations.
Respondents need to understand the survey questions if they are going to provide reliable data.
New office in Lyon, France, enhances our capabilities in real-world evidence generation
RTI Health Solutions' parent company, RTI International is a 2019 recipient of the Triangle Business Journal’s Leaders in Diversity award. The Leaders in Diversity Awards program, now in its seventh year, recognizes the accomplishments of Triangle businesses, individuals, and nonprofits who have...
To leverage ICER’s evaluations as opportunities to communicate the value of health technologies, we at RTI Health Solutions recommend a proactive, efficient, and strategic approach in preparing for each evaluation.
New research co-authored by RTI-HS researchers and published in Patient helps bring greater understanding of patient perspectives in hematologic cancers, particularly acute myeloid leukemia. The researchers analyzed information from a targeted literature review alongside patient-...
This study assesses the incidence rates of skeletal related events from the time of castration resistance.
Mary Beth was recommended for this honor by a committee of her peers.
Can the CIRS-BRAT framework also be used for drug delivery combination products?
Valid real-world evidence depends on being able to accurately identify exposures of interest in real-world data.
As a result of these findings, a validated coding algorithm updated to ICD-10 codes to identify psychosis associated with dementia is recommended.
we conducted an antidepressant drug utilization study in five databases in Denmark, Germany, Spain and Sweden.
When using observational data, quantifying the effect of treatment strategies that are sustained over time is not straightforward
ICER's influence on pharmaceutical policy is gaining traction. Here are keys to successful collaboration for evaluations.
A recent population-based observational study highlights important real-world evidence on treatment patterns, health care burden, occurrence of adverse events, and survival outcomes after a metastatic breast cancer (MBC) diagnosis, in particular among older women with the HR+/HER2–subtype in the...
At the Alzheimer’s Association International Conference in July, UsAgainstAlzheimer’s (UsA2) released “Preparing Us for a Cure,” three research products on key areas of Alzheimer’s disease that impact the lives of patients, caregivers, and communities.
Pregnancy-related PASSs are increasingly relying on real-world data to assess potential safety issues that could not be assessed in pre-approval clinical trials.
Atopic dermatitis (AD) and chronic hand eczema (CHE)—both often simply referred to as eczema—are among the most common dermatologic diseases. These conditions cause significant patient burden related to constant, intense itching, visible skin effects, impaired ability to interact with...
At the 16th annual RTI Authors' Awards Dinner held this month, RTI Health Solutions researchers were recognized for their research publishing achievements.
Real-world evidence on adherence, persistence, switching, and dose escalation with biologics in adult IBD in the US is limited.